Japan's Takeda Seals $62 Billion Takeover of Adderall Maker Shire

Reuters
Japan's Takeda reaches a deal to buy London-listed Shire for $61.5 billion after weeks of negotiations.
Shareholders still need to approve the deal and Shire shares are trading at below the offer price, suggesting shareholders could have reservations about the deal.
Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion ($61.50 billion) on Tuesday after the Japanese company raised the amount of cash in ...
Read Full Article